Thrombopoietin mimetics

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Acyclic nitrogen double bonded to acyclic nitrogen – acyclic...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C534S753000, C534S775000, C534S792000, C548S183000, C548S366100, C560S020000, C560S043000, C564S461000

Reexamination Certificate

active

07414040

ABSTRACT:
Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

REFERENCES:
patent: 2132193 (1938-10-01), Schuster et al.
patent: 3728115 (1973-04-01), Poot et al.
patent: 4948900 (1990-08-01), Iijima et al.
patent: 7160870 (2007-01-01), Duffy et al.
patent: WO-01/89457 (2001-11-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thrombopoietin mimetics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thrombopoietin mimetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombopoietin mimetics will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4004598

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.